Disclosure Information

Financial disclosure information is current as of January 2015 and forward. Information is limited to financial relationships with commercial entities that have products in the field of hepatitis C. AASLD defines a direct financial relationship requiring disclosure as a compensated relationship with a company, by an individual, that should generate an IRS Form W2-1099.

Current Chairs


Personal Financial Relationships: None
Institutional Research: Dr. Chung was awarded research grants, paid to his institution, from AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, MassBiologics, and Merck & Co, Inc.
Updated: 07/12/2016

Personal Financial Relationships: None
Institutional Research: Dr. Kim was awarded research grants, paid to his institution, from AbbVie and Gilead Sciences, Inc.
Updated: 08/05/2016

Personal Financial Relationships: None
Institutional Research: Dr. Naggie was awarded research grants, paid to her institution, from AbbVie, Benitec Biopharma, Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Merck & Co, Inc, Tacere, and Vertex Pharmaceuticals.
Updated: 07/12/2016

Personal Financial Relationships: None
Institutional Research: Dr. Vargas was awarded research grants, paid to his institution, from AbbVie, Gilead Sciences, Inc, and Merck & Co, Inc.
Updated: 08/04/2016

Current Panel Members


Personal Financial Relationships: None
Institutional Research: None
Updated: 07/11/2016

Personal Financial Relationships: None
Institutional Research: Dr. Bhattacharya received study drugs, given to her institution for research trials, from AbbVie, Bristol-Myers Squibb, and Merck & Co, Inc.
Updated: 08/18/2016

Personal Financial Relationships: None
Institutional Research: Ms. Broder's organization was awarded grants from AbbVie, Bristol-Myers Squibb, Janssen, Gilead Sciences, Inc, Merck & Co, Inc, and OraSure Technologies, Inc.
Updated: 11/07/2016

Personal Financial Relationships: None
Institutional Research: None
Updated: 07/08/2016

Personal Financial Relationships: Dr. Fontana served on the data and safety monitoring board for Tibotec Therapeutics. He received research support from Bristol-Myers Squibb and Gilead Sciences, Inc. He serves as a consultant to Regulus Pharmaceuticals, Alynam pharmaceuticals, and Abbvie. He also serves on the scientific advisory board of Regulus Pharmaceuticals.
Institutional Research: Dr. Fontana was awarded research grants, paid to his institution, from Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Vertex Pharmaceuticals, Inc.
Updated: 01/16/2017

Personal Financial Relationships: None
Institutional Research: None
Updated: 09/02/2016

Personal Financial Relationships: Dr. Gordon serves on scientific advisory boards for AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, and Merck & Co, Inc.
Institutional Research: Dr. Gordon was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, and Merck & Co, Inc.
Updated: 01/17/2017

Personal Financial Relationships: None
Institutional Research: None
Updated: 08/18/2016

Personal Financial Relationships: None
Institutional Research: None
Updated: 07/07/2016

Personal Financial Relationships: None
Institutional Research: None
Updated: 09/15/2016

Personal Financial Relationships: Dr. Jonas serves as a scientific consultant to AbbVie and Gilead Sciences, Inc.
Institutional Research: Dr. Jonas was awarded research grants, paid to her institution, from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, and Roche.
Updated: 10/17/2016

Personal Financial Relationships: None
Institutional Research: Dr. Kiser was awarded research grants, paid to her institution, from Janssen Therapeutics, Inc.
Updated: 07/09/2016

Personal Financial Relationships: None
Institutional Research: None
Updated: 07/11/2016

Personal Financial Relationships: None
Institutional Research: None
Updated: 03/11/2017

Personal Financial Relationships: None
Institutional Research: Dr. Marks was awarded research grants, paid to her institution, from Gilead Sciences, Inc, and Merks & Co, Inc.
Updated: 07/12/2016

Personal Financial Relationships: None
Institutional Research: Dr. Morgan was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, Genentech, Gilead Sciences, Inc, Merck & Co, Inc, and Roche.
Updated: 09/30/2015

Personal Financial Relationships: None
Institutional Research: Dr. Nahass was awarded research grants, paid to his institution, from Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Merck & Co, Inc.
Updated: 07/07/2016

Personal Financial Relationships: Dr. Peters' husband is an employee/officer/director and has stock options at Hoffman La Roche.
Institutional Research: None
Updated: 01/18/2017

Personal Financial Relationships: None
Institutional Research: Mr. Raymond’s organization was awarded educational grants from Genentech, Gilead Sciences, Inc, and Janssen Therapeutics, Inc.
Updated: 01/14/2015

Personal Financial Relationships: Dr. Reddy serves on advisory boards for AbbVie, Bristol-Myers Squibb, Genentech, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Merck & Co, Inc, and Vertex Pharmaceuticals, Inc.
Institutional Research: Dr. Reddy was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Merck, and Vertex Pharmaceuticals, Inc.
Updated: 08/22/2016

Personal Financial Relationships: None
Institutional Research: Mr. Reynolds’s organization was awarded educational grants from AbbVie, Bristol-Myers Squibb, Genentech, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Mercks & Co, Inc, OraSure Technologies, Inc, and Roche.
Updated: 10/14/2015

Personal Financial Relationships: None
Institutional Research: Dr. Scott was awarded research grants, paid to his institution, from Merck & Co, Inc.
Updated: 02/15/2017

Personal Financial Relationships: Ms. Searson serves on the Hepatitis Consumer Advisory Board.
Institutional Research: Ms. Searson's organization was awarded grants from AbbVie, Bristol-Myers Squibb, Janssen, Gilead Sciences, Inc, and Merck & Co, Inc.
Updated: 01/16/2017

Personal Financial Relationships: None
Institutional Research: None
Updated: 07/12/2016

Personal Financial Relationships: Dr. Terrault serves on the medical affairs boards of Gilead Sciences, Inc (uncompensated) and Merck & Co, Inc. She serves on the marketing advisory boards of AbbVie (uncompensated) and on the scientific advisory board of Biotest. She also serves as a consultant to AbbVie, Biotest, CoCrystal Pharmaceuticals, and Gilead Sciences, Inc.
Institutional Research: Dr. Terrault was awarded research grants, paid to her institution, from AbbVie, Gilead Sciences, Inc, Merck & Co, Inc., and Vertex Pharmaceuticals, Inc.
Updated: 01/27/2017

Personal Financial Relationships: Dr. Trooskin serves on the advisory board (ceased as of December 2016) and is a consultant for Gilead Sciences, Inc.
Institutional Research: Dr. Trooskin was awarded research grants, paid to her institution, from Gilead Sciences, Inc, and Gilead Sciences Foundation.
Updated: 01/18/2017

Personal Financial Relationships: None
Institutional Research: None
Updated: 11/18/2016

Personal Financial Relationships: None
Institutional Research: Dr. Workowkski was awarded research grants, paid to her institution, from AbbVie, Bristol-Myers Squibb, and Gilead Sciences, Inc.
Updated: 09/27/2016

Top